AI litigation brief
Paragard remains active mdl with 3 current signals in the accepted feed.
Overview
Law360 news on Mar 5: Teva Renews Interlocutory Appeal Motion On Preemption In Paragard IUD MDL - Law360. This is the lead item in the current accepted signal set.
Key developments
- PACER court filing on Feb 23: Zieve v. Teva Pharmaceuticals USA, Inc.
- Law360 news on Mar 5: Teva Renews Interlocutory Appeal Motion On Preemption In Paragard IUD MDL - Law360
Trajectory
Court filings and press coverage are both active in MDL 2974, pointing to sustained litigation pressure rather than a one-off headline cycle. 4 live sources are contributing current context.
Editorial intelligence
MDL 2974 should stay on the lead docket watch because it is the primary consolidation vehicle for Paragard.
Generated Mar 11, 2026, 10:16 PM UTC